4DMedical

I mean, we're sitting at a 280 mil valuation right now for a pre-revenue stock.

Um, you know, we've seen some of these names, again, I know they're in the healthcare space, but we've seen like 4D Medical, Artria.

Mm-hmm.

The market can really extrapolate these things very far, um, because until you have revenue, you know, the potential's endless.

Now, the other side of that coin is Blue Scope Steel.

Trading ex-dividend, 4D Medical, AUB trading ex-dividend, Judo Bank.

I was just scanning a piece written by Joe Astin on Judo.

So there you go.

Aura Banda also firmer by 6.5%.

DroneShield Life 360 and 4D Medical.

while the laggards include Knight Entertainment, we touched on that Bruce Gordon stake, and Ampol and Viva Energy, which both traded without rights to their dividends today.

Let's have a look at some of the small winners, including White Energy Company up 38%, Karma up by more than 13%, and the laggards in the small end of town included corporate travel once again being sold off.

In the sense that...

Let's take 4D Medical.

So 4D Medical was the best performing company of the, of the, um, last 12 months.

Yeah.

The company grew from, let's say $120 million valuation to $2.3 billion valuation within the space of four months, um, after they managed to get 510k approval and investment from Pro- Promedicus and started to commercialize their product.

So I can, you know, discount or add whatever value it is to whatever that, whatever that acquisition was done." So I think that there are definitely ways in which you can benchmark the value of the company based on where it's at in the, i- in terms of like what they've been able to validate and also what external validation exists.

And I think that the number one external validation that the retail investors look for is probably in the market itself.

So if you see a 4D medical running, everyone's asking themselves, "Okay, what's the next AI imaging company?" Because the market's given 4D Medical a $2.3 billion valuation, and then surprise, surprise, two months, three months later, AIQ goes from a 20 mil market cap company or s- a 50 mil market cap company to a billion-dollar market cap company, and Pro Medicus then goes and invests in them because, you know, they, they, they see that, you know, the market is rewarding this subsector of the healthcare industry, which happens to be AI medical imaging.